Drug Type Universal CAR-T |
Synonyms FKC-389 |
Target |
Action modulators |
Mechanism BCMA modulators(B-cell maturation protein modulators), CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Myelodysplastic-Myeloproliferative Diseases | Clinical | China | 26 May 2026 | |
| Autoimmune Diseases | Preclinical | China | 01 Apr 2026 | |
| Hematologic Neoplasms | Preclinical | China | 01 Apr 2026 |





